We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

35 hedge funds and large institutions have $50.3M invested in Assembly Biosciences in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

223% more capital invested

Capital invested by funds: $15.5M → $50.3M (+$34.7M)

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

33.92% more ownership

Funds ownership: 16.17% → 50.09% (+34%)

17% more funds holding

Funds holding: 30 → 35 (+5)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
10
Increased
11
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$468K
2
Man Group
Man Group
United Kingdom
+$315K
3
PWM
Palumbo Wealth Management
New York
+$184K
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$174K
5
JP Morgan Chase
JP Morgan Chase
New York
+$127K

Top Sellers

1
AC
Armistice Capital
New York
-$2.99M
2
AI
Acuitas Investments
Washington
-$943K
3
Millennium Management
Millennium Management
New York
-$569K
4
Citadel Advisors
Citadel Advisors
Florida
-$193K
5
Amundi
Amundi
France
-$114K
Name Holding Trade Value Shares
Change 		Change in
Stake
GS
1
Gilead Sciences
California
$34.9M +$35.6M +2,209,471 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.16M – – –
AC
3
Armistice Capital
New York
$2.65M -$2.99M -185,926 -53%
Renaissance Technologies
4
Renaissance Technologies
New York
$1.49M +$468K +29,087 +44%
BlackRock
5
BlackRock
New York
$1.29M +$71.2K +4,421 +6%
PLC
6
Peapod Lane Capital
New York
$994K +$1.01M +62,970 New
BGI
7
B Group Inc
Texas
$799K +$815K +50,651 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$736K -$6.42K -399 -0.8%
MCM
9
Monimus Capital Management
New Jersey
$664K +$677K +42,067 New
Northern Trust
10
Northern Trust
Illinois
$452K -$18.9K -1,175 -4%
Federated Hermes
11
Federated Hermes
Pennsylvania
$401K – – –
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$339K +$90.1K +5,597 +35%
Man Group
13
Man Group
United Kingdom
$309K +$315K +19,567 New
Fidelity Investments
14
Fidelity Investments
Massachusetts
$277K +$27.5K +1,711 +11%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$255K +$42.6K +2,646 +20%
Marshall Wace
16
Marshall Wace
United Kingdom
$234K +$33.8K +2,098 +16%
BCM
17
Bridgeway Capital Management
Texas
$221K -$7.65K -475 -3%
State Street
18
State Street
Massachusetts
$221K +$19.3K +1,200 +9%
PWM
19
Palumbo Wealth Management
New York
$180K +$184K +11,427 New
JP Morgan Chase
20
JP Morgan Chase
New York
$180K +$127K +7,918 +226%
Connor, Clark & Lunn Investment Management (CC&L)
21
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$171K +$174K +10,813 New
MAM
22
Marquette Asset Management
Minnesota
$142K – – –
UBS Group
23
UBS Group
Switzerland
$103K +$84.4K +5,246 +403%
Barclays
24
Barclays
United Kingdom
$47.2K -$660 -41 -1%
Morgan Stanley
25
Morgan Stanley
New York
$47.1K +$5.25K +326 +12%
1
2

ASMB Hedge Fund Activity: Q4 2024 in Review

35 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2024, worth a combined $50.3M — up 223% from $15.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ASMB positions and 5 closed out — a net gain of 5 holders — while 11 added to existing stakes and 7 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $468K. The largest seller was Armistice Capital, cutting an estimated $2.99M.

  • 35 institutional investors held Assembly Biosciences (ASMB) as of Q4 2024, up from 30 in Q3 2024.
  • Funds reported $50.3M of Assembly Biosciences stock for Q4 2024, up 223% quarter-over-quarter.
  • 10 funds opened new Assembly Biosciences positions in Q4 2024 and 5 closed out, a net change of +5 holders.
  • The largest Assembly Biosciences buyer in Q4 2024 was Renaissance Technologies, an estimated $468K added.
  • The largest Assembly Biosciences seller in Q4 2024 was Armistice Capital, an estimated $2.99M sold.

Based on aggregated 13F filings for Q4 2024.